Picture of D.Western Therapeutics Institute logo

4576 — D.Western Therapeutics Institute News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: D.Western Therapeutics Institute to buy ophthalmic surgical adjuvant business from Healios KK

Feb 1 (Reuters) - D.Western Therapeutics Institute Inc   
 4576.T : 
     
     
    * Says the co to buy ophthalmic surgical adjuvant business, 
which includes ingredient of Brilliant Blue G-250, from Healios 
KK 4593.T  
    * Says the acquisition price is set at 1.3 billion yen 
    * Says effective date on April 30 
     
     
    Source text in Japanese:https://goo.gl/2zf5HO; 
https://goo.gl/CmNCme 
    Further company coverage: 4576.T  4593.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))

Recent news on D.Western Therapeutics Institute

See all news